SAN FRANCISCO, Jan 8 – Investors are expected to take a “back to basics” approach to genomics during 2001 as they seek companies that are generating revenues from fully developed technologies, Rob Olan, a life science technology analyst at JP Morgan H&Q, said Monday. 

“In general, the atmosphere is going to be less euphoric,” Olan told GenomeWeb at the start of the JP Morgan H&Q healthcare conference. “Companies that are more established will do better.” 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.